REIN THERAPEUTICS INC (RNTX) Stock Analyst Ratings
NASDAQ:RNTX - Nasdaq - US00887A2042 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 85% to RNTX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 10.2. This target is 460.44% above the current price.
RNTX was analyzed by 8 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about RNTX.
In the previous month the buy percentage consensus was at a similar level.
RNTX was analyzed by 8 analysts. More opinions would make the average more meaningful.